Fitoterapia
Cure8 research brief
Why This Matters
A traditional medicine formulation (Hudi capsules) relieved colitis signs in mice and appears to stimulate Wnt/β-catenin–dependent epithelial regeneration, which could point to new therapeutic directions for mucosal healing in IBD.
Who Should Pay Attention
Researchers (preclinical and translational), clinicians interested in regenerative approaches and IBD therapeutics, and investigators of traditional medicine compounds.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The authors identified chemical constituents of the preparation and tested it in mice given dextran sulfate sodium (DSS) to induce colitis. Treated mice showed less weight loss, less diarrhea and bloody stool, reduced inflammatory cell infiltration, lower colon cytokine levels, and higher expression of tight junction proteins and mucins.
Transcriptome and protein analyses implicated activation of Wnt/β-catenin signaling and Abca12-related inhibition of GSK-3β as possible mechanisms. The study used 16S rRNA sequencing for microbiome-related analysis and correlation approaches.
This is an animal (mouse) model and an experimental formulation; the findings do not demonstrate safety or efficacy in people with IBD. The study provides mechanistic data that could support further preclinical work or early-phase clinical research but should not be taken as clinical evidence to change treatment.
Keep In Mind
This is preclinical research in a DSS mouse model; findings suggest mechanisms but do not establish clinical safety or efficacy. The report includes transcriptomics and microbiome (16S) data but is not a human clinical trial.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFitoterapia
AuthorsHui Guo, Ying Liu, Qiong Wang +8 more
InstitutionDepartment of Laboratory Medicine, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedJul 16, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ
A natural compound (C3G) reduced inflammation and changed gut bacteria and metabolites in an experimental colitis model, pointing to possible new mechanisms or leads for IBD therapies.
Chitosan-coated and sodium phytate-crosslinked porous starch microspheres for oral delivery of celastrol in colitis therapy.
The study describes a new oral-delivery microsphere that improved loading and gut-targeted release of celastrol and showed beneficial effects in a mouse colitis model and on gut microbiota. If translatable, this approach...
Orally administered biomimetic nanovesicles engineered with FGF2 orchestrate mucosal healing and microbiome remodeling in inflammatory bowel disease.
Researchers are exploring new ways to deliver regenerative factors and reshape the gut microbiome in IBD.